İçeriğe geç

Perioperatif Bakım

Uygun Hemostaz (Kanamanın Durması)

Antifibrinolitik İlaçlar

Alternatives to allogeneic platelet transfusion. (opens new window)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Kaynak‎: Br J Haematol 2016;175(3):381-92.

İndeks‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (opens new window)

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (opens new window)

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K.

Kaynak‎: Cochrane Database Syst Rev 2011;(3):CD001886.

İndeks‎: PubMed 21412876

DOI‎: 10.1002/14651858.CD001886.pub4

https://www.ncbi.nlm.nih.gov/pubmed/21412876 (opens new window)

Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. (opens new window)

Howell N, Senanayake E, Freemantle N, Pagano D.

Kaynak‎: J Thorac Cardiovasc Surg 2013;145(1):234-40.

İndeks‎: PubMed 22889481

DOI‎: 10.1016/j.jtcvs.2012.07.018

https://www.ncbi.nlm.nih.gov/pubmed/22889481 (opens new window)

Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. (opens new window)

Taeuber I, Weibel S, Herrmann E, Neef V, Schlesinger T, Kranke P, Messroghli L, Zacharowski K, Choorapoikayil S, Meybohm P

Kaynak‎: JAMA Surg 2021;156(6):e210884.

İndeks‎: PubMed 33851983

DOI‎: 10.1001/jamasurg.2021.0884

https://www.ncbi.nlm.nih.gov/pubmed/33851983 (opens new window)

Rekombinant Aktive Faktör VII (rFVIIa)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (opens new window)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Kaynak‎: Transfusion 2009;49 Suppl 5:240S-7S.

İndeks‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (opens new window)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (opens new window)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Kaynak‎: Circulation 2008;118(4):331-8.

İndeks‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (opens new window)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (opens new window)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Kaynak‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

İndeks‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (opens new window)

Consensus recommendations for the off-label use of recombinant human factor VIIa (NovoSeven(R)) therapy. (opens new window)

Shander A, Goodnough LT, Ratco T, Matuszewski KA, Cohn S, Diringer M, Edmunds H, Lawson J, MacLaren R, Ness P, Shere-Wolfe R, Dubois R.

Kaynak‎: Pharm Ther 2005;30(11):644-58.

İndeks‎: EMBASE 2005576568

https://www.ptcommunity.com/journal/article/archives/2005/11/644/consensus-recommendations-label-use-recombinant-human-factor-0 (opens new window)

Pıhtılaşma Faktörü Konsantreleri

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (opens new window)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Kaynak‎: Ann Thorac Surg 2009;88(5):1666-8.

İndeks‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (opens new window)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (opens new window)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Kaynak‎: A A Case Rep 2015;4(10):140-2.

İndeks‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (opens new window)

Fibrinogen replacement therapy: a critical review of the literature. (opens new window)

Franchini M, Lippi G.

Kaynak‎: Blood Transfus 2012;10(1):23-7.

İndeks‎: PubMed 22153684

DOI‎: 10.2450/2011.0015-11

https://www.ncbi.nlm.nih.gov/pubmed/22153684 (opens new window)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (opens new window)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Kaynak‎: Thromb Haemost 2009;102(1):137-44.

İndeks‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (opens new window)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (opens new window)

Levy JH, Welsby I, Goodnough LT.

Kaynak‎: Transfusion 2014;54(5):1389-405.

İndeks‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (opens new window)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (opens new window)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Kaynak‎: Anesthesiology 2013;118(1):40-50.

İndeks‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (opens new window)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (opens new window)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Kaynak‎: Can J Anaesth 2012;59(3):299-303.

İndeks‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (opens new window)

Desmopresin

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (opens new window)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Kaynak‎: Anaesthesia 2010;65(7):688-91.

İndeks‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (opens new window)

Cerrahiye ya da Pıhtılaşma Bozukluğuna Bağlı Kanamanın Tespitinde Viskoelastik Testler

Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. (opens new window)

Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, Fries D, Görlinger K, Haas T, Imberger G, Jacob M, Lancé M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelsø AJ, Wouters P, Wyffels P.

Kaynak‎: Eur J Anaesthesiol 2013;30(6):270-382.

İndeks‎: PubMed 23656742

DOI‎: 10.1097/EJA.0b013e32835f4d5b

https://www.ncbi.nlm.nih.gov/pubmed/23656742 (opens new window)